Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial - Wikidata - awgldk - TriplyDB

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

http://www.wikidata.org/entity/Q28216474

about

sameAs

Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Pathogenesis of Helicobacter pylori infection The stomach in health and disease Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond Should we eradicate Helicobacter pylori in non-steroidal anti-inflammatory drug users?Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?Celecoxib inhibits Helicobacter pylori colonization-related factors.Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks.Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.Approach to Helicobacter pylori infection in geriatric population.A fibreoptic endoscopic study of upper gastrointestinal bleeding at Bugando Medical Centre in northwestern Tanzania: a retrospective review of 240 cases Role of aspirin in cancer prevention.Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage.Assessment of Helicobacter pylori eradication in patients on NSAID treatment Estimates of benefits and harms of prophylactic use of aspirin in the general population.Clinical Rationale for Confirmation Testing After Treatment of Helicobacter pylori Infection: Implications of Rising Antibiotic Resistance.Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights Helicobacter pylori infection in geriatrics.Helicobacter pylori: when is treatment now indicated?Efficacy of serology driven "test and treat strategy" for eradication of H. pylori in patients with rheumatic disease in the Netherlands.Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide.Trends in peptic ulcer pharmacotherapy.Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.Management issues in dyspepsia: current consensus and controversies.Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.Cost Effectiveness Associated with Helicobacter pylori Screening and Eradication in Patients Taking Nonsteroidal Anti-Inflammatory Drugs and/or Aspirin.Ageing and the gut Helicobacter pylori: present status and future prospects in Japan.Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcers.Current management of Helicobacter pylori infections in the elderly.The association of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in peptic ulcer disease.Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole

P2860

Q24247126-E07EC368-9DC4-4017-8005-9C6E595A4E5C Q24248627-F74A0979-C2FC-4FD2-9A23-32210A748603 Q24674636-409FD420-C51B-489D-BF44-D7E58693ECB8 Q24679810-2AE358B2-22C7-456A-B646-892E46F822BA Q26784036-00CA5819-6183-47E7-B1F8-760F05C5E51E Q28182449-FF782EA8-EBE0-4AF0-8709-B64488F67390 Q28192701-9405DF11-7311-4D99-9DA8-9899913E02F8 Q28195079-D4DD137B-BA0C-4205-81E1-7C1EBC000853 Q28200569-9FE8EE08-A7E1-4F6F-B9AC-895527FD7A2F Q28200571-13C9C841-36D5-4D9E-87D9-A968E719CF73 Q28210656-FAF83996-73B8-49B9-9E84-150B1D9813AE Q28211894-165782EF-D4A8-413A-B027-19124C60A922 Q28213638-B14A19D7-093C-40D3-BCF6-ED13DD0FFB88 Q33530350-7CA6CABD-E760-432D-BB05-E078E1A77D6F Q33678007-A05CC66F-7A7A-4382-98D3-5349B32B8469 Q33698340-059D7046-7AF7-4488-B2C3-B7C2B743E7CA Q34047658-D61DEB62-32FB-4A59-B409-B69094F95D86 Q34248511-6EF803ED-BF5E-4315-88C7-36E7DF11450F Q34376832-E987B973-1A2C-4859-80BA-7519D6D6CC76 Q34387174-8C2A526E-FF46-447D-9706-43EC419542FF Q34420397-7BE9DEED-F8FC-4B1B-8589-29F5999B5A63 Q34432503-14990C4F-36A2-480F-9C3D-EED277F64026 Q34448307-1C8642A3-4C67-4498-AAB2-82236EEB4E13 Q34655792-0DD2729B-C6AF-4E78-9E2C-6E048319DDAA Q34663572-A30E2A4D-D296-4A13-AC00-8DE145DD9809 Q34799624-7C47263B-0233-4F0E-B0B7-8513D3DDA556 Q34966240-2FFA3B4F-3B86-4417-9802-B90323682CC4 Q35013830-EC15EA3C-A5A8-4185-8F54-5FA0CA88F88B Q35202215-525B596D-2062-4641-B39E-DA13D6AA277D Q35641362-D34F4C71-895E-4553-BBB3-4C92B0C0F2DB Q35739112-2740FEAA-2CEF-4D0F-98FA-02253115379C Q35932402-EECAC0A3-3A86-4C7F-8728-549808FDA4C6 Q36158848-D2DAFE3E-5154-4654-8045-6DC94F8C9C7E Q36715136-4C9AA4B1-174A-490E-9D9D-9E78614CDA8F Q36724430-42BCEF3E-E4CC-4EC1-A614-314EC421C1EC Q36745437-4EC29C71-75F8-4709-AF41-9A0CB66E0E98 Q36808048-2717FC47-DC38-4A55-A84D-88620B03097A Q36960071-80D56AC3-3C91-4DF8-8505-F9113FF6F3D8 Q37138362-00AF146F-7EB7-46E2-9594-D28341A59C11 Q37260543-BAE0BE34-866C-4C69-92D3-9C97AD596F18

P2860

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

http://www.wikidata.org/entity/Q28216474

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Eradication of Helicobacter py ...... tory drugs: a randomised trial

@ast

Eradication of Helicobacter py ...... tory drugs: a randomised trial

@en

Eradication of Helicobacter py ...... tory drugs: a randomised trial

@nl

type

label

Eradication of Helicobacter py ...... tory drugs: a randomised trial

@ast

Eradication of Helicobacter py ...... tory drugs: a randomised trial

@en

Eradication of Helicobacter py ...... tory drugs: a randomised trial

@nl

prefLabel

Eradication of Helicobacter py ...... tory drugs: a randomised trial

@ast

Eradication of Helicobacter py ...... tory drugs: a randomised trial

@en

Eradication of Helicobacter py ...... tory drugs: a randomised trial

@nl

P1433

Q28216474-FB4914C1-56DF-45BD-BBFB-F8DA41B5CA01

P1476

Q28216474-66A565B3-D940-4060-9D1F-E99305FB31C2

P2093

Q28216474-0DAF44FE-0342-43CF-8B56-DEE40639F67E

Q28216474-27A3310F-4B02-4AB3-9946-E333EAA785CA

Q28216474-2B367549-877A-41EA-84A8-99952F714D06

Q28216474-2C6BD84C-95B5-4BFF-821F-1E66B0E81BB2

Q28216474-3045268F-E953-49D0-A50D-65F1E67E1F4C

Q28216474-522F1BFB-03DD-4D18-ACF3-285C37C8C944

Q28216474-A458BB60-B0FF-40E6-9731-5FCC378684D9

Q28216474-ADFE6725-4F21-4E10-97B6-92289259BBFC

Q28216474-C09CE906-EB26-45BD-9B46-FB674DB9C286

Q28216474-CFBB2AF6-7BA8-4C5E-99A9-F543762017EC

P304

Q28216474-DF9C4091-FF80-4467-80FC-F995C11B5CA9

P31

Q28216474-9792FCD9-BD47-42E3-A949-3FC4CA53DBFD

P356

Q28216474-CAA0CD6C-CD93-40AA-A2C1-840BFB6B8BE1

P407

Q28216474-9ACF276F-1753-4BFF-A19B-CD9F619FFF4F

P433

Q28216474-7A8C1AFD-52E0-442C-B7BD-CDF5E9AAEEA1

P478

Q28216474-6101741E-A233-48EA-9ABE-8A0D7DA4DAAA

P577

Q28216474-6AC9A356-AC70-4DBA-8F1A-D149F816F458

P698

Q28216474-676E4499-6D6D-48C3-BD21-0353DA706332

P921

Q28216474-410276B7-98E2-498F-A18E-EDB110CAE2AC

Q28216474-57ADE090-731E-4E20-BBCB-BCF85064600D

Q28216474-B610D650-4A66-42E4-BC1C-2607756BD480

P356

S0140-6736(02)07272-0

P1433

P1476

Eradication of Helicobacter py ...... tory drugs: a randomised trial

@en

P2093

Cynthia S Y Chan

http://www.w3.org/2001/XMLSchema#string

Elsie Hui

http://www.w3.org/2001/XMLSchema#string

Francis K L Chan

http://www.w3.org/2001/XMLSchema#string

Henry L Y Chan

http://www.w3.org/2001/XMLSchema#string

Jean Woo

http://www.w3.org/2001/XMLSchema#string

Joseph J Y Sung

http://www.w3.org/2001/XMLSchema#string

Justin C Y Wu

http://www.w3.org/2001/XMLSchema#string

K F To

http://www.w3.org/2001/XMLSchema#string

M Y Yung

http://www.w3.org/2001/XMLSchema#string

Timothy Kwok

http://www.w3.org/2001/XMLSchema#string

P304

9-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(02)07272-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

9300

http://www.w3.org/2001/XMLSchema#string

P478

359

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11809180

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori